Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
0.3249
+0.0149 (4.81%)
At close: Mar 11, 2026, 4:00 PM EDT
0.3300
+0.0051 (1.57%)
After-hours: Mar 11, 2026, 4:32 PM EDT

Cue Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
3267125123364380
Market Cap Growth
-60.66%-45.94%1.61%-66.32%-4.08%-9.96%
Enterprise Value
16.0845.9383.560.44304.96297.2
Last Close Price
0.321.092.642.8511.3112.51
PE Ratio
--1.51-2.38-1.91-8.02-8.02
PS Ratio
4.277.2622.7098.5324.38120.37
PB Ratio
1.823.853.361.875.564.81
P/TBV Ratio
2.113.513.261.555.404.55
P/FCF Ratio
--1.85-3.12-2.92-9.16-11.47
P/OCF Ratio
--1.85-3.12-2.93-9.38-11.69
EV/Sales Ratio
2.264.9515.2148.5420.4194.22
EV/EBITDA Ratio
--1.12-1.62-1.16-7.18-6.76
EV/EBIT Ratio
--1.11-1.60-1.14-6.98-6.60
EV/FCF Ratio
--1.26-2.09-1.44-7.67-8.98
Debt / Equity Ratio
0.200.060.200.210.080.03
Debt / EBITDA Ratio
-0.16-0.22-0.28-0.37-0.24-0.16
Debt / FCF Ratio
-0.21-0.24-0.37-0.46-0.25-0.22
Net Debt / Equity Ratio
-0.94-0.78-0.91-0.87-0.83-0.98
Net Debt / EBITDA Ratio
0.330.330.661.091.281.77
Net Debt / FCF Ratio
0.420.370.851.361.372.35
Asset Turnover
0.220.200.070.010.160.04
Quick Ratio
1.351.712.946.615.285.29
Current Ratio
1.661.843.016.685.355.36
Return on Equity (ROE)
-245.13%-149.03%-98.73%-80.82%-61.16%-67.10%
Return on Assets (ROA)
-119.56%-88.56%-68.25%-60.94%-48.33%-52.88%
Return on Invested Capital (ROIC)
-598.43%-884.96%-740.38%-518.55%-408.82%-479.03%
Return on Capital Employed (ROCE)
-220.45%-131.85%-83.99%-70.80%-56.83%-62.92%
Earnings Yield
-124.26%-66.06%-42.05%-52.28%-12.47%-12.47%
FCF Yield
-98.32%-54.01%-32.06%-34.22%-10.91%-8.71%
Buyback Yield / Dilution
-35.51%-21.14%-11.12%-35.71%-5.28%-15.44%
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q